Brain

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study

World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria…

1 year ago

FDA authorizes the first AI-driven MRI solution for safer Alzheimer’s treatment

BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's…

1 year ago

Paul VS Tyson – BHOUT, the first punching bag with a brain, partners with the most significant sports event of the decade

LISBON, Portugal, Nov. 13, 2024 /PRNewswire/ -- The BHOUT Bag, world's first "punching bag with a brain" developed by Portuguese…

1 year ago

Ethics Board Approval Granted for Lexaria’s 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp.…

1 year ago

The Menninger Clinic Offering Nation’s First Rapid Targeted Transcranial Magnetic Stimulation to Treat Depression

Menninger is the only hospital in the U.S. to offer groundbreaking treatment HOUSTON, TX / ACCESSWIRE / November 13, 2024…

1 year ago

Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder

Novel Hyperbaric Oxygen Therapy Shows Promise in Treating Combat-Related PTSD in Veterans, lessening symptoms with lifechanging outcomesORLANDO, Fla., Nov. 13,…

1 year ago

PreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints President

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

1 year ago

mediaire transforms radiology with AI, securing a European €12 million investment to fuel global growth

BERLIN and PARIS, Nov. 13, 2024 /PRNewswire/ -- While Generative AI is creating a buzz across industries and remains in the…

1 year ago

Cosmos Health Issues Letter to Shareholders

CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

1 year ago

Siegel Rare Neuroimmune Association Hosts 2024RNDS

Educational conference focused on diagnosis, research and treatment of rare neuroimmune disordersPOWELL, OH / ACCESSWIRE / November 12, 2024 /…

1 year ago